Tilray Brands, Inc. - Common Stock (TLRY)

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Cannabis stocks jumped as Trump reportedly pushes SAFE Banking behind the scenes—but analysts warn: don't chase the hype just yet.

Tilray launches new whiskey. Recently it planned a reverse split to meet Nasdaq listing standards.

Tobacco company Philip Morris International (NYSE:PM) will be reporting earnings tomorrow before market open. Here’s what investors should know.

The past, present, and future of the Canadian cannabis sector.

Cannabis news this week: Congress revives cannabis reform, Slovenia leads Europe, Tyson takes charge and science backs cannabis for cancer care.

Tilray shares are trading lower by 6.2% during Thursday's session. The company on Thursday announced plans to implement a reverse stock split.

Tilray shares fall 6.8% after announcing a proposed reverse stock split ahead of a June 10 shareholder vote.

Tilray Brands Inc. (NASDAQ: TLRY) has launched its first medical cannabis edibles in Australia through Tilray Medical. The new sugar-free, vegan Good Supply Pastilles offer THC and CBD options, enhancing patient access to plant-based therapies.

The past, present and futur eof the Canasian cannabis sector.

Cannabis news of the week: Germany holds CanG, US delays, Chile bill; Italy hemp ban; SNDL expands, Tilray cuts outlook, US sales forecast –$21 B.

The past, present, and future of the Canadian cannabis sector.

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 19.7% in the afternoon session after the company reported weak fiscal third-quarter 2025 results that missed analysts' sales and EBITDA estimates, signaling ongoing challenges in growing its top line.